Novel Formulations for Pediatric Infections

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".

Deadline for manuscript submissions: 28 February 2026 | Viewed by 13

Special Issue Editors


E-Mail Website
Guest Editor
Centre for Rapid and Sustainable Product Development, Polytechnic Institute of Leiria, 2430-028 Leiria, Portugal
Interests: additive manufacturing; antimicrobial materials; biomaterials; chromatography; drug delivery systems; gene therapy; tissue engineering
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
School of Chemistry, Chemical Engineering and Life Sciences, Wuhan University of Technology, Wuhan 430070, China
Interests: pharmacology and toxicology; drug delivery; miRNA; nanoparticles; bacteria and virus
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Mother and Baby, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania
Interests: pediatrics; pediatric gastroenterology and nutrition

E-Mail Website
Guest Editor
Research Methodology Department, Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania
Interests: physical chemistry and drug design; pharmacology; biomedical applications of bioceramics; nanotechnology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Infectious diseases in the pediatric population present distinct clinical and pharmacological complexities due to age-dependent variations in immune function, organ maturity, and drug metabolism. Neonates and young children differ markedly from adults in their response to both pathogens and pharmacotherapy, necessitating age-specific dosing strategies and therapeutic monitoring. The rising prevalence of antimicrobial resistance further complicates treatment, driving the need for precise antibiotic stewardship tailored to developmental pharmacokinetics and pharmacodynamics. Current research is focused on optimizing pediatric-specific formulations, leveraging pharmacogenomics to predict drug response, and integrating rapid diagnostic tools that can support early, targeted intervention. As our understanding of the pediatric immune landscape evolves, so too must our approach to designing and delivering anti-infective therapies that are both safe and effective across all stages of childhood.

Dr. Joana Valente
Prof. Dr. Zhixin Lei
Dr. Cristina Elena Singer
Dr. Renata Maria Văruț
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • drug resistance
  • pediatric infection
  • drug metabolism
  • antibiotic complications

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop